🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Here’s more excellent scientific work from our Melanoma Institute Australia translational research team on the influence of the tumour #microenvironment on responses to #immunotherapy.

Happy to meet with good friends and thanks for supporting my poster! Darren Poon Claudia PARISI, MD Stephen V Liu, MD Inês Pires da Silva Xiuning Le MD PhD Melvin LK CHUA | FRCR, PhD, FASCO Tom Wei-Wu Chen

And 7 years later… I became an Australian Citizen! 🇦🇺🇵🇹

Massive congrats to @amenzies9 & Rebecca Simpson 4 richly deserved awards: Outstanding MidCareer Researcher & Rising Star PhD Candidate at 2023 NSW Premier's Cancer Research Awards today. Professor Georgina Long AO (Bluesky @gvlongphdmd) & I so proud our Melanoma Institute Australia team culture continues generating up & coming stars!

Amazing! Congratulations @amenzies9! 👏👏👏

Congratulations Professor Georgina Long AO (Bluesky @gvlongphdmd) & @ProfRScolyerMIA!!!! 👏👏👏👏

Our Australians of the Year! @ProfRScolyerMIA Professor Georgina Long AO (Bluesky @gvlongphdmd) Melanoma Institute Australia 🇦🇺🦘👏🥳

Very well deserved! Congratulations to Professor Georgina Long AO (Bluesky @gvlongphdmd) and @ProfRScolyerMIA! 👏👏👏

Well done @brownjlauren and Ben Kong 👏👏👏

Congratulations @brownjlauren! 👏👏👏🇦🇺

🎉 Congratulations to our medicine and health researchers: Dr Tuba Gide Dr Dr Camelia Quek Dr Nicholas Hunt Dr Shania Liu Dr Anagha Killedar Dr Dr Katrina Prior Dr Aleksandra PETROVIC FABIJAN A/Prof Ines Esteves Domingues Pires da Silva Dr Emma Devenney Prof David Beard Prof Anthony Cunningham

NEW content online! Exploiting temporal aspects of cancer immunotherapy dlvr.it/T8Q0kd

a combined effort from Professor Georgina Long AO (Bluesky @gvlongphdmd) , Inês Pires da Silva , Elsa Anagnostou and Joost Lesterhuis telethonkids @telethonkidsCC Fred Hutch Cancer Center Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Melanoma Institute Australia University of Sydney Charles Perkins Centre

At #ESMO24, 1 of A/Prof Inês Pires da Silva's 2 posters detailed #NeoRisk predictive tool for neoadjuvant therapy response. Tool takes into account patient’s demographics, disease characteristics + pathological & imaging data. Will help guide treatment. bit.ly/3zq0pXi ESMO - Eur. Oncology

Fantastic #melanoma conference - Society for Melanoma Congress 2024 in USA! Melanoma Institute Australia team presented on #neoadjuvant #immunotherapy, artificial intelligence for pathological response & immune tumour microenvironment. Also on our personalised immunotherapy platform (PIP) &

Inspiring #AMC2024 discussions: 'Overview of peri-operative systemic therapies'- neodjuvant therapy, histopathology & surgery considerations, personalised vaccines, clinical stage II & III melanoma @amenzies9 Rachel Roberts-Thomson David Gyorki Inês Pires da Silva #VictoriaAtkinson #RobertRawson

Brilliant #AMC2024 session this morning on 'Primary resistance to immunotherapy in melanoma: What's next'? presented by Inês Pires da Silva, Grant McArthur, Rachel Roberts-Thomson & Olivier Michielin. This session concluded with an insightful panel discussion. #TogetherAmplifyingImpact

nature.com/articles/s4159… This #science is exciting! It shows the power of vision & action in an inspired team. Within 12 days of 1st dose of triple combination #immunotherapy in #glioblastoma 1) >8x more immune cells in the #GBM, 2) immune cells were newly activated & 3) PD1 drug

Congratulations Jorja Braden! 👏👏👏

INNOVATE conference Naples - I love this think tank meeting! 2nd yr colleague Paolo Ascierto has hosted small but lively group of clinician researchers, clinical trialists and drug developers discuss an ALL #CANCER #NEOADJUVANT #immunotherapy approach.  It is one of my favourite